{
	"l1liv0yeText": "Study Design",
	"l1liv0yfText": "Brintellix® demonstrates a dose-response<br>relationship across a broad range of MDD symptoms<span class=\"fs4 v2\">1</span>",
	"l1liv0yqText": "Brintellix® ",
	"l1liv0yrText": "10–20 mg/day (n=100)",
	"l1liv0ysText": "BRIN",
	"l1liv0ytText": "10 mg/",
	"l1liv0yuText": "day",
	"Brintellix_NewAss_7c6c3036c": "<span style=\"color: rgb(77, 127, 134); font-family: '2_TKMNLA+AvenirNextLTPro-Bold';\"><font style=\"font-size: 25px;\">References</font></span>",
	"Brintellix_NewAss_776fd33fe": "<div style=\"line-height: 1.4;\"><font style=\"font-size: 15px; font-family: &quot;1_EUSBJE+AvenirNextLTPro-Demi&quot;; color: rgb(100, 94, 94);\"><b style=\"\">1.</b></font> <font style=\"font-size: 15px; font-family: '5_SCCHXC+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);\">Christensen MC et al. CNS Spectr. 2021 Oct 18;1-26. doi:10.1017/S1092852921000936.</font><br>\n<font style=\"font-size: 15px; font-family: '1_EUSBJE+AvenirNextLTPro-Demi'; color: rgb(100, 94, 94);\"><b style=\"\">2.</b></font> <font style=\"font-size: 15px; font-family: '5_SCCHXC+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);\">Christensen MC et al. CNS Spectr. 2021 Oct 18 (Suppl material);1-26. doi:10.1017 S1092852921000936.</font></div>",
	"Brintellix_NewAss_9ccd52984": "<font style=\"color:#645e5e; font-size:21px; font-family: '1_EUSBJE+AvenirNextLTPro-Demi';\">Mean difference in change in MADRS single items at week 8<sup style=\"font-size:50%;\">‡</sup> in a<br>meta-analysis of six short term, fixed-dose, placebo-controlled studies</font>",
	"Brintellix_NewAss_904a6f326": "<div style=\"text-align:center; color:#5f6a72; font-size:11px; font-family: '1_EUSBJE+AvenirNextLTPro-Demi';\">Mean difference in MADRS score from basline vs. placebo</div>",
	"Brintellix_NewAss_9e2d0e0d2": "<div style=\"text-align:left; color:#645e5e; font-size:11px; font-family: '1_EUSBJE+AvenirNextLTPro-Demi';\">Apparent<br>sadness</div>",
	"Brintellix_NewAss_9939d8697": "<div style=\"text-align:left; color:#645e5e; font-size:11px; font-family: '1_EUSBJE+AvenirNextLTPro-Demi';\">Reported<br>sadness</div>",
	"Brintellix_NewAss_9aac8a453": "<div style=\"text-align:left; color:#645e5e; font-size:11px; font-family: '1_EUSBJE+AvenirNextLTPro-Demi';\">Inner tension</div>",
	"Brintellix_NewAss_903e432f5": "<div style=\"text-align:left; color:#645e5e; font-size:11px; font-family: '1_EUSBJE+AvenirNextLTPro-Demi';\">Reduced sleep</div>",
	"Brintellix_NewAss_9629b5110": "<div style=\"text-align:left; color:#645e5e; font-size:11px; font-family: '1_EUSBJE+AvenirNextLTPro-Demi';\">Reduced<br>appetite</div>",
	"Brintellix_NewAss_9f7f86c25": "<div style=\"text-align:left; color:#645e5e; font-size:11px; font-family: '1_EUSBJE+AvenirNextLTPro-Demi';\">Lassittude</div>",
	"Brintellix_NewAss_9bb10d765": "<div style=\"text-align:left; color:#645e5e; font-size:11px; font-family: '1_EUSBJE+AvenirNextLTPro-Demi';\">Inhability<br>to feel</div>",
	"Brintellix_NewAss_9770ff191": "<div style=\"text-align:left; color:#645e5e; font-size:11px; font-family: '1_EUSBJE+AvenirNextLTPro-Demi';\">Pessimistic<br>thoughts</div>",
	"Brintellix_NewAss_97595ec37": "<div style=\"text-align:left; color:#645e5e; font-size:11px; font-family: '1_EUSBJE+AvenirNextLTPro-Demi';\">Suicidal<br>thoughts</div>",
	"Brintellix_NewAss_9ee3be231": "<div style=\"text-align:left; color:#645e5e; font-size:11px; font-family: '1_EUSBJE+AvenirNextLTPro-Demi';\">Concentration<br>difficulties</div>",
	"Brintellix_NewAss_9a79fef6c": "<div style=\"color:#646162; font-size:17px; font-family: '5_SCCHXC+AvenirNextLTPro-Regular'; text-indent:-15px; margin-bottom:20px;\"><b style=\"color:#f28700; font-family: '2_TKMNLA+AvenirNextLTPro-Bold'; font-size:25px;\">•</b> Improvements across a broad range of depressive symptoms were seen for Brintellix<sup style=\"font-size:50%;\">®</sup> vs placebo across<br>the dose range of 10 mg -20 mg<sup style=\"font-size:50%;\">1</sup></div>\n\n<div style=\"color:#646162; font-size:17px; font-family: '5_SCCHXC+AvenirNextLTPro-Regular'; text-indent:-15px;\"><b style=\"color:#f28700; font-family: '2_TKMNLA+AvenirNextLTPro-Bold'; font-size:25px;\">•</b> The most pronounced therapeutic benefit across MDD symtoms is seen with 20 mg, with statistically<br>significant improvements vs placebo on all MADRS single items<sup style=\"font-size:50%;\">1</sup></div>",
	"Brintellix_NewAss_95c32d638": "<div style=\"color:#5f6a72; font-size:11px; font-family: '5_SCCHXC+AvenirNextLTPro-Regular';\">\n<sup style=\"font-size:50%;\">‡</sup>In these fixed-dose studies, patients who were assigned to receive vortioxetine 20 mg received a 10 mg dose for the first week of the 8-week<br>study.<br>\n*p&lt;0.05; **p&lt;0.01; ***p&lt;0.001.\n</div>",
	"Brintellix_NewAss_1051c097b3": "<div style=\"color:#569099; font-size:9px; font-family: '5_SCCHXC+AvenirNextLTPro-Regular';\">Brintellix<sup style=\"font-size:50%;\">®</sup> 10 mg (n=660)</div>",
	"Brintellix_NewAss_108d53c9a0": "<div style=\"color:#cd66cc; font-size:9px; font-family: '5_SCCHXC+AvenirNextLTPro-Regular';\">Brintellix<sup style=\"font-size:50%;\">®</sup> 15 mg (n=294)</div>",
	"Brintellix_NewAss_10d51c5e7e": "<div style=\"color:#5f6a72; font-size:9px; font-family: '5_SCCHXC+AvenirNextLTPro-Regular';\">Brintellix<sup style=\"font-size:50%;\">®</sup> 20 mg (n=963)</div>"
}
